JP2015536933A5 - - Google Patents

Info

Publication number

JP2015536933A5

JP2015536933A5 JP2015539704A JP2015539704A JP2015536933A5 JP 2015536933 A5 JP2015536933 A5 JP 2015536933A5 JP 2015539704 A JP2015539704 A JP 2015539704A JP 2015539704 A JP2015539704 A JP 2015539704A JP 2015536933 A5 JP2015536933 A5 JP 2015536933A5

Authority

JP

Japan

Prior art keywords

antibody

use according

seq

neuroendocrine cancer

heavy chain

Prior art date

2013-10-22

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 101710181403 Frizzled Proteins 0.000 claims description 28
• 239000005557 antagonist Substances 0.000 claims description 27
• 201000002120 neuroendocrine carcinoma Diseases 0.000 claims description 17
• 125000003275 alpha amino acid group Chemical group 0.000 claims description 14
• 239000003814 drug Substances 0.000 claims description 9
• 108020003175 receptors Proteins 0.000 claims description 8
• 102000005962 receptors Human genes 0.000 claims description 8
• 108010012934 Albumin-Bound Paclitaxel Proteins 0.000 claims description 6
• 201000002530 pancreatic endocrine carcinoma Diseases 0.000 claims description 6
• 229940124597 therapeutic agent Drugs 0.000 claims description 6
• 102100028466 Frizzled-8 Human genes 0.000 claims description 4
• 101001061408 Homo sapiens Frizzled-8 Proteins 0.000 claims description 4
• 206010028980 Neoplasm Diseases 0.000 claims description 4
• 201000011510 cancer Diseases 0.000 claims description 4
• 208000002458 carcinoid tumor Diseases 0.000 claims description 4
• SDUQYLNIPVEERB-QPPQHZFASA-N gemcitabine Chemical compound O=C1N=C(N)C=CN1[C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1 SDUQYLNIPVEERB-QPPQHZFASA-N 0.000 claims description 4
• 229960005277 gemcitabine Drugs 0.000 claims description 4
• 239000008194 pharmaceutical composition Substances 0.000 claims description 4
• 102100021259 Frizzled-1 Human genes 0.000 claims description 2
• 102100021265 Frizzled-2 Human genes 0.000 claims description 2
• 102100039818 Frizzled-5 Human genes 0.000 claims description 2
• 102100039676 Frizzled-7 Human genes 0.000 claims description 2
• 101100447415 Homo sapiens FZD8 gene Proteins 0.000 claims description 2
• 101000819438 Homo sapiens Frizzled-1 Proteins 0.000 claims description 2
• 101000819477 Homo sapiens Frizzled-2 Proteins 0.000 claims description 2
• 101000885585 Homo sapiens Frizzled-5 Proteins 0.000 claims description 2
• 101000885797 Homo sapiens Frizzled-7 Proteins 0.000 claims description 2
• 108010021625 Immunoglobulin Fragments Proteins 0.000 claims description 2
• 102000008394 Immunoglobulin Fragments Human genes 0.000 claims description 2
• 108010069515 OMP-54F28 Proteins 0.000 claims description 2
• 206010061332 Paraganglion neoplasm Diseases 0.000 claims description 2
• 229940028652 abraxane Drugs 0.000 claims description 2
• 239000002246 antineoplastic agent Substances 0.000 claims description 2
• 229940127089 cytotoxic agent Drugs 0.000 claims description 2
• 230000002496 gastric effect Effects 0.000 claims description 2
• 230000002401 inhibitory effect Effects 0.000 claims description 2
• 208000007312 paraganglioma Diseases 0.000 claims description 2
• 208000028591 pheochromocytoma Diseases 0.000 claims description 2
• 230000002685 pulmonary effect Effects 0.000 claims description 2
• RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims description 2
• 230000002992 thymic effect Effects 0.000 claims description 2
• 210000001685 thyroid gland Anatomy 0.000 claims description 2
• 238000004519 manufacturing process Methods 0.000 claims 2
• 238000002512 chemotherapy Methods 0.000 claims 1
• 229940043355 kinase inhibitor Drugs 0.000 claims 1
• 239000003757 phosphotransferase inhibitor Substances 0.000 claims 1
• NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical class C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 claims 1
• 230000007717 exclusion Effects 0.000 description 1